Patents Assigned to Cambridge Bioclinical Limited
  • Potassium channel activators and their use
    Patent number: 6342517
    Abstract: Novel thienopyran compounds are disclosed, useful as anti-hypertensive agents and for asthma treatment. One group of the compounds has a heterocyclic ring spiro-connected at the 7-position of the thienopyran ring structure. Use of thienopyran compounds in hair growth modulation is described.
    Type: Grant
    Filed: December 3, 1999
    Date of Patent: January 29, 2002
    Assignee: Cambridge Bioclinical Limited
    Inventors: Peter Esch, Franz Rovenszky, Robertson Towart, Thomas Christoph, Michael Hartmann, George Terence Evelyn Kealey